Evidence map›Paper›PMID 41377374›Full record

ArticleAnnals of medicine and surgery (2012)2025

Guillain-Barré Syndrome in war-torn regions: the forgotten neurological emergency in humanitarian crises.

Zahabia Adnan, Amna Kashif, Ahmed Asad Raza, Abedin Samadi

Abstract readLetter
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zahabia AdnanDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Amna KashifDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.
Ahmed Asad RazaDepartment of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan.ORCID https://orcid.org/0009-0004-2930-8188
Abedin SamadiDepartment of Medicine, Kabul University of Medical Sciences, Kabul, Afghanistan.ORCID https://orcid.org/0009-0004-2676-9093

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guillain-Barré Syndrome (GBS) is a life-threatening neurological emergency and the leading cause of acute flaccid paralysis in the post-polio era. While extensively studied in stable healthcare systems, its impact in conflict-affected regions remains underrecognized. This paper highlights GBS as a neglected but significant health crisis in war-torn settings, where collapsing sanitation systems, overcrowded shelters, and widespread infections act as key triggers. Data from recent humanitarian emergencies, including Gaza, reveal rising incidence and mortality due to inadequate surveillance, scarce diagnostic capacity, and lack of access to intravenous immunoglobulin or plasmapheresis. Unlike high-income countries, where timely ICU care keeps mortality under 5%, patients in low-resource conflict zones often experience prolonged disability or death. Addressing this disparity requires practical, low-cost interventions such as early recognition training for frontline workers, provision of essential supportive care, and international advocacy for humanitarian supply corridors. Remote digital consultations and safe patient evacuation can further enhance outcomes. Incorporating GBS into humanitarian response frameworks is an urgent necessity to reduce preventable neurological deaths. By bringing attention to this overlooked emergency, the manuscript underscores the moral and medical imperative of ensuring equitable neurological care during crises.

Indexed as

conflict zonesglobal healthGuillain–Barré syndromehumanitarian crisesneurological emergency

Identifiers

PMID41377374
PMCPMC12688712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.